Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 29, 2023 04:00 ET | Source: Macomics Limited

Macomics Expands in Edinburgh with Move to Roslin Innovation Centre and Announces Appointment of Professor Paul Crocker to SAB

EDINBURGH and CAMBRIDGE, United Kingdom, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Macomics Ltd, a leader in macrophage drug discovery, continues its growth trajectory with expansion in Edinburgh into...
September 29, 2023 02:46 ET | Source: Adlai Nortye Ltd.

Adlai Nortye Ltd. Announces Pricing of Initial Public Offering

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage...
September 28, 2023 21:00 ET | Source: Vaccinex, Inc.

Vaccinex Announces Pricing of $9.6 Million Public Offering

ROCHESTER, N.Y., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a differentiated approach to...
September 28, 2023 17:19 ET | Source: Biosenta Inc

Biosenta Announces Breakthrough Discovery in Anti-Microbial Efficacy of Tri-Filler™ in Collaboration with Dr. Ian Lewis and Dr. Maen Husein's Labs

TORONTO and CALGARY, Alberta, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. (“Biosenta” or the “Company”) (CSE: ZRO) is thrilled to announce a pivotal discovery led by Dr. Mehdi Mohammadi Ashani,...
September 28, 2023 16:56 ET | Source: Theriva Biologics, Inc.

Theriva Biologics participará en la Conferencia sobre crecimiento emergente

ROCKVILLE, Maryland, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), empresa diversificada de fase clínica que investiga tratamientos antineoplásicos y enfermedades...
September 28, 2023 16:29 ET | Source: TFF Pharmaceuticals, Inc.

TFF Pharmaceuticals to Participate in Upcoming Investor Conferences

FORT WORTH, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug...
September 28, 2023 16:15 ET | Source: Wave Life Sciences USA, Inc.

Wave Life Sciences Highlights Growth Strategy for Building the Leading RNA Medicines Company in Annual R&D Day

Presented preclinical proof-of-concept data for new, wholly owned program targeting INHBE for metabolic disorders, including obesity, which uses Wave’s best-in-class GalNAc-siRNA capabilities and...
September 28, 2023 16:15 ET | Source: Nanobiotix S.A.

NANOBIOTIX annonce la présentation des premières données de l’étude de phase 1 évaluant NBTXR3 chez des patients atteints d’un cancer du pancréas localement avancé

Données présentées lors de la réunion 2023 sur le cancer du pancréas de l’American Association for Cancer Research Les données préliminaires montrent que l’injection endoscopique locale de NBTXR3...
September 28, 2023 16:15 ET | Source: Nanobiotix S.A.

NANOBIOTIX Announces Presentation of First Data From Phase 1 Study Evaluating NBTXR3 for Patients With Locally Advanced Pancreatic Cancer

Data presented at the 2023 Special Meeting on Pancreatic Cancer of the American Association for Cancer Research Preliminary data show local endoscopic injection of NBTXR3 followed by radiotherapy...
September 28, 2023 16:05 ET | Source: QIAGEN N.V.

QIAGEN erweitert KI-Funktionen seiner NGS‑Interpretationssoftware QCI Interpret zur vollständigen Abdeckung des klinischen Exoms

QIAGENs proprietäre, human-zertifizierte Inhalte durch KI-gesteuerte Literaturextraktion für tausende Gene seltener Krankheiten erweitert; vollständige bibliografische Abdeckung des klinischen Exoms...